The continuing need for therapeutic agents for respiratory syncytial virus infection
{{output}}
Respiratory syncytial virus infections recur throughout life despite induction of immunity by the first natural infection. An effective vaccine has long been sought but no vaccine is currently licensed, although promising candidates are currently being develop... ...